Novel thiosemicarbazones induce high toxicity in estrogen-receptor-positive breast cancer cells (MCF7) and exacerbate cisplatin effectiveness in triple-negative breast (MDA-MB231) and lung adenocarcinoma (A549) cells.

Published in:

Investigational New Drugs, 2020, v. 38, n. 3, p. 558, doi. 10.1007/s10637-019-00789-1

By:

• Medina-Reyes, Estefany Ingrid;
• Mancera-Rodríguez, Marco Antonio;
• Delgado-Buenrostro, Norma Laura;
• Moreno-Rodríguez, Adriana;
• Bautista-Martínez, Juan Luis;
• Díaz-Velásquez, Clara Estela;
• Martínez-Alarcón, Stefanía Andrea;
• Torrens, Hugo;
• de los Ángeles Godínez-Rodríguez, María;
• Terrazas-Valdés, Luis Ignacio;
• Chirino, Yolanda Irasema;
• Vaca-Paniagua, Felipe

Publication type:

Article